Ivometn Ivermectin Lice Treatment
NDC 87276-003
Product Information
Ivometn Ivermectin Lice Treatment is a OTC MONOGRAPH DRUG-approved product labeled by Shenzhen Zhenshangzekai Technology Co., Ltd.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a white product. This product entry covers the primary NDC 87276-003 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 87276-003?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- IVERMECTIN (UNII: 8883YP2R6D)
- IVERMECTIN (UNII: 8883YP2R6D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GLYCERIN (UNII: PDC6A3C0OX)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- SHEA BUTTER (UNII: K49155WL9Y)
- SORBITAN TRISTEARATE (UNII: 6LUM696811)
- METHYLPARABEN (UNII: A2I8C7HI9T)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PROPYLPARABEN (UNII: Z8IX2SC1OH)
- WATER (UNII: 059QF0KO0R)
- ANHYDROUS TRISODIUM CITRATE (UNII: RS7A450LGA)
- STEARYL ALCOHOL (UNII: 2KR89I4H1Y)
- BUTYLATED HYDROXYANISOLE (UNII: REK4960K2U)
- OLEYL ALCOHOL (UNII: 172F2WN8DV)
- CETYL ALCOHOL (UNII: 936JST6JCN)
- IMIDUREA (UNII: M629807ATL)
- CYCLOMETHICONE (UNII: NMQ347994Z)
- LANOLIN ALCOHOLS (UNII: 884C3FA9HE)
- OLIVE OIL (UNII: 6UYK2W1W1E)
- CASTOR OIL (UNII: D5340Y2I9G)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1246673 - ivermectin 0.5 % Topical Lotion
- RxCUI: 1246673 - ivermectin 5 MG/ML Topical Lotion
* Please review the full disclaimer at the bottom of this page.